GE HealthCare Technologies (GEHC) Set to Announce Quarterly Earnings on Wednesday

GE HealthCare Technologies (NASDAQ:GEHC) is set to issue its quarterly earnings data before the market opens on Wednesday, October 30th. Analysts expect the company to announce earnings of $1.06 per share for the quarter. GE HealthCare Technologies has set its FY 2024 guidance at 4.200-4.350 EPS and its FY24 guidance at $4.20-4.35 EPS.Parties interested in listening to the company’s conference call can do so using this link.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, topping analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a net margin of 8.10% and a return on equity of 25.26%. The business had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same quarter in the previous year, the firm posted $0.92 EPS. The firm’s revenue was up .5% on a year-over-year basis. On average, analysts expect GE HealthCare Technologies to post $4 EPS for the current fiscal year and $5 EPS for the next fiscal year.

GE HealthCare Technologies Trading Down 2.8 %

Shares of GEHC stock opened at $85.93 on Tuesday. GE HealthCare Technologies has a 1 year low of $62.35 and a 1 year high of $94.55. The firm has a fifty day moving average price of $88.43 and a 200-day moving average price of $83.40. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.06 and a quick ratio of 0.82. The company has a market cap of $39.22 billion, a price-to-earnings ratio of 25.13, a PEG ratio of 3.34 and a beta of 1.18.

GE HealthCare Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.14%. The ex-dividend date of this dividend is Friday, October 18th. GE HealthCare Technologies’s payout ratio is 3.51%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on the stock. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a research report on Thursday, August 1st. Stifel Nicolaus boosted their price objective on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a research report on Monday, September 30th. UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and cut their price objective for the company from $84.00 to $74.00 in a research report on Thursday, September 26th. BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 target price for the company in a report on Wednesday, September 18th. Finally, Evercore ISI upped their target price on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $94.23.

Insiders Place Their Bets

In other GE HealthCare Technologies news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the sale, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.